Vir Biotechnology Inc.
VIR | NASDAQ
$10.88
+$0.28 (+2.64%)
At close: Sep 21, 2026, 4:00 PM ET
$11.31
+$0.43 (+3.95%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $1.79B
Enterprise Value $1.4B
Beta 1.63
Average Volume 1.83M
Shares Outstanding (Diluted) 168.88M
Shares Change YoY 21.98%
Institutional Ownership 94.68%
Exchange NASDAQ
ISIN US92764N1028
Price Performance
Price Change 1M 11.7%
Price Change 3M 7.1%
Price Change 6M 21.0%
Price Change YTD 83.2%
Price Change 1Y 106.5%
Price Change 3Y 16.4%
Price Change 5Y -75.2%
1M CAGR (ann.) 20.9%
1Y CAGR (ann.) 120.8%
5Y CAGR (ann.) -27.2%
All-Time CAGR -4.0%
Valuation
PE Ratio -5.85
Forward PE N/A
PEG Ratio -0.08
Forward PEG -0.13
PS Ratio 6.05
Forward PS 24.90
PB Ratio 1.87
P/FCF Ratio -5.53
P/Adj. FCF Ratio -4.85
P/OCF Ratio -5.44
EV/Sales 4.62
EV/EBIT -5.47
EV/EBITDA -5.73
EV/FCF -4.22
Earnings Yield -17.1%
FCF Yield -18.1%
Adj. FCF Yield -20.6%
Financial Health
Net Cash $528.59M
Total Debt $93.27M
Cash & Short-Term Investments $528.59M
Total Assets $1.21B
Current Ratio 6.04
Quick Ratio 6.04
Debt / Equity Ratio 0.09
Debt / EBITDA -0.38
Debt / FCF -0.28
OCF / Debt -3.59
Interest Coverage 0.00
Altman Z-Score 3.21
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 170.0%
Operating Profit Margin -89.0%
EBITDA Margin -80.6%
Net Profit Margin -83.0%
FCF Margin -109.3%
Adj. FCF Margin -124.8%
SBC / Revenue 15.5%
SBC Impact (per share) -14.2%
Returns
Return on Assets -20.7%
Return on Equity -30.0%
Return on Invested Capital -23.9%
Return on Capital Employed -24.1%
Return on Tangible Assets -21.1%
Historical Growth (CAGR)
Revenue CAGR 3Y -14.8%
Revenue CAGR 5Y 11.2%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 27.3%
EPS CAGR 5Y -320.1%
EPS CAGR 10Y N/A
FCF CAGR 3Y 15.2%
FCF CAGR 5Y -553.6%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y 3.1%
Revenue Growth Next 3Y -11.9%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$0.74
EPS Growth Est (next Q) -36.8%
Revenue Est (next Q) $865.13K
Revenue Growth Est (next Q) 260.5%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $25
Price Target Upside 129.8%
Cash Flow
Operating Cash Flow $-334.89M
Free Cash Flow $-331.54M
Adj. Free Cash Flow $-378.58M
FCF Per Share -$1.98
OCF Per Share -$2
OCF/S Ratio -110.4%
Income Statement
Revenue $303.23M
Gross Profit $515.53M
Operating Income $-269.77M
EBITDA $-244.41M
Net Income $-251.68M
EPS (Diluted) -$1.86
Revenue / Employee $826.23K
Profit / Employee $-685.77K
Employees 367
Add to Watchlist
Select watchlists to add or remove VIR